| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Domperidone poisoning |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Accidental domperidone poisoning |
Causative agent (attribute) |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Intentional domperidone poisoning |
Causative agent (attribute) |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| intoxication par la dompéridone d'intention indéterminée |
Causative agent (attribute) |
False |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone adverse reaction |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Allergy to domperidone (finding) |
Causative agent (attribute) |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Domperidone overdose |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Accidental domperidone overdose |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Intentional domperidone overdose |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| surdose de dompéridone d'intention indéterminée |
Causative agent (attribute) |
False |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone(motility) [see chapter d for preparations] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Domperidone [nausea] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely domperidone 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely domperidone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Product containing domperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone maleate (substance) |
Is a |
False |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Accidental domperidone poisoning |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Intentional domperidone poisoning |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Allergy to domperidone (finding) |
Causative agent (attribute) |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely domperidone 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 10 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone maleate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
|
| Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 10 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 1 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone (as domperidone maleate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone and pantoprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone and pantoprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone and pantoprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone- and pantoprazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone (as domperidone maleate) 30 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone 10 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone 10 mg orodispersible tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Dexrabeprazole and domperidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing dexrabeprazole and domperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Dexrabeprazole- and domperidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Dexrabeprazole and domperidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Dexrabeprazole sodium 10 mg and domperidone 30 mg gastro-resistant and prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing domperidone and omeprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing domperidone and omeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing only domperidone and omeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Domperidone and omeprazole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Domperidone 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone 30 mg and pantoprazole (as pantoprazole sodium) 40 mg gastro-resistant and prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only domperidone and rabeprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing domperidone and rabeprazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone and rabeprazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Domperidone 30 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
2 |
| Domperidone- and rabeprazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 10 milligram and pantoprazole (as pantoprazole sodium) 20 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely domperidone 10 milligram and pantoprazole (as pantoprazole sodium) 20 milligram/1 each gastro-resistant oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Domperidone (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]